Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Withdrawn Phase 2 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0029916 (Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01670084Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous LeukemiaTreatment